Home » Topics » BioWorld Science

BioWorld Science
RSS

Japanese regulatory agency approves Allergan's Botox for cervical dystonia

June 28, 2001

GPC Biotech delivers seven antimicrobial targets to Byk Gulden

June 28, 2001

Long-term therapy with DPP IV inhibitor may be beneficial in diabetes

June 28, 2001

GenVec and Varian Medical extend collaborative agreement for treatment of cancer

June 28, 2001

Bone remodeling reduced by TSE-424 in prospective trial in postmenopausal women

June 28, 2001

Ciprofloxacin GR proves suitable for once-daily dosing in phase I study

June 28, 2001

Novartis prepares new somatostatin analogues with improved therapeutic profile

June 28, 2001

Antidiabetic effects and excellent pharmacokinetics described for new PTP1B inhibitor

June 28, 2001

Glycogen phosphorylase inhibitor + metformin combinations effective and safe in ob/ob mice

June 28, 2001

Genistein derivative shows raloxifene-like SERM profile

June 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...